ArticleHemaSphere2019

Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With

Gauthier Decool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.